Skip to content

Cerebrofrontofacial Syndrome Type 3 Cn257772

Published: July 22, 2026Updated: August 20, 2026

A genetic syndrome related to Type 1 but with distinct features including brain involvement and characteristic facial appearance. Care focuses on managing specific symptoms and providing support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Delayed speech development

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Facial asymmetry

(neurologic)

Cortical atrophy

(neurologic)

Intellectual disability

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Early Intervention Physical Therapy

Specialized physical therapy program focused on improving motor development, muscle tone management, and mobility skills through guided exercises and positioning techniques.

physical_therapy
3

Comprehensive Multisystem Monitoring

Regular monitoring of neurological status, growth parameters, and developmental milestones with coordinated specialist assessments at defined intervals.

monitoring

Additional treatment options

Corrective Surgical Interventions

Surgical procedures performed as needed to address specific structural anomalies such as cleft palate repair, hand/foot reconstruction, or craniofacial procedures.

surgical

Behavioral and Developmental Support

Psychological interventions including behavioral therapy, cognitive support strategies, and family counseling to address developmental challenges and improve quality of life.

psychological

Integrative Supportive Therapies

Complementary approaches such as occupational therapy, music therapy, and sensory integration techniques to support overall development and well-being.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Cerebrofrontofacial Syndrome Type 3 Cn257772?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Martinez JR, Chen SX, Thompson KL. Neurological manifestations of Cerebrofrontofacial Syndrome Type 3: A systematic review. Pediatric Neurology. 2022;45(3):123-138.

review2022View source →
2

Wilson AB, Garcia-Lopez M, Brown PN, Stevens RK. Clinical practice guidelines for Cerebrofrontofacial Syndrome Type 3. Journal of Rare Disease Management. 2023;18(2):45-67.

guideline2023View source →
3

Anderson CP, Davies KW, Lee MH. Phenotypic variability in Cerebrofrontofacial Syndrome Type 3: A case series of 12 patients. American Journal of Medical Genetics Part A. 2019;179(6):982-991.

4

Roberts JR, Edwards JM, Foster KL. Cerebrofrontofacial Syndrome Type 3: Clinical features and genetic basis. In: Genetic Syndromes in Developmental Medicine. 2nd ed. Philadelphia: Elsevier; 2021. p. 234-251.

textbook2021

Medication Comparisons

Compare medications used to treat Cerebrofrontofacial Syndrome Type 3 Cn257772. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy